PMID: 7593708Aug 1, 1995Paper

Triazolam pharmacokinetics after intravenous, oral, and sublingual administration

Journal of Clinical Psychopharmacology
P D KrobothR Smith

Abstract

This study was designed to evaluate the relative and absolute bioavailability of triazolam, 0.25 mg, after the administration of the marketed oral tablet and a sublingual prototype wafer; an intravenous dose was used as a reference. Twelve men were evaluated in a three-way crossover study; study days were separated by 1 week. A single dose was administered to each subject at approximately 8 a.m.; serial blood samples were obtained for the determination of triazolam concentration. The fraction absorbed relative to intravenous was 20% higher in the sublingual than in the oral treatment (p = 0.0128); the difference between treatments was greatest in the first 2 hours as indicated by the area under the curve from 0 to 2 hours (p < 0.05). The extraction ratio ranged from 0.05 to 0.25, and the predicted availability after oral administration was 86% with a range of 75 to 95%. In contrast, the observed mean absolute availability was 44% (oral) and 53% (sublingual). A potential explanation for this discrepancy between predicted and observed bioavailability is that after oral administration, a fraction of triazolam may be metabolized by cytochrome P450IIIA4 in the gut wall, with a separate fraction subject to first-pass metabolism in th...Continue Reading

References

May 20, 1992·Journal of Chromatography·T EdekiA J Wood
Jun 13, 1991·The New England Journal of Medicine·D J GreenblattR I Shader
Nov 1, 1985·Clinical Pharmacology and Therapeutics·P D KrobothR P Juhl
Mar 1, 1988·Journal of Clinical Pharmacology·H FriedmanR I Shader
Dec 1, 1987·Journal of Clinical Pharmacology·R SmithP D Varner
Dec 1, 1986·British Journal of Clinical Pharmacology·H FriedmanR I Shader
Oct 1, 1986·Journal of Clinical Psychopharmacology·J P PhillipsR Smith
Feb 1, 1986·Journal of Clinical Pharmacology·R SmithJ P Phillips
Mar 1, 1986·Journal of Clinical Pharmacology·J M ScavoneR I Shader
Sep 1, 1971·Journal of Pharmaceutical Sciences·M GibaldiS Feldman
Feb 1, 1980·British Journal of Clinical Pharmacology·A N Nicholson, B M Stone
Jan 1, 1981·Clinical Pharmacology and Therapeutics·F S EbertsR W Vliek
Jan 1, 1982·Psychopharmacology·C L Spinweber, L C Johnson
Jan 1, 1981·British Journal of Clinical Pharmacology·T RothE Stepanski
Jan 1, 1983·British Journal of Clinical Pharmacology·W H ZieglerM Eckert

Citations

Dec 14, 2002·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·J L C M DorneA G Renwick
Jul 7, 2000·Journal of Clinical Pharmacology·G H KamimoriN D Eddington
Jul 20, 2002·Clinical Pharmacokinetics·Hao ZhangJames B Streisand
Feb 18, 2014·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Guillaume BaneyxThierry Lavé
Sep 1, 2012·AAPS PharmSciTech·Jeremy A Bartlett, Kees van der Voort Maarschalk
Apr 7, 2006·Anesthesia Progress·Steven I GanzbergF Michael Beck
May 24, 2007·Drug Development and Industrial Pharmacy·Mutasem M Rawas-QalajiKeith J Simons
Oct 26, 2011·Drug Development and Industrial Pharmacy·Azza A Mahmoud, Salwa Salah
Apr 29, 2016·Journal of Forensic Sciences·Hannu Lauerma
Jul 11, 2006·British Journal of Clinical Pharmacology·Teijo I SaariK T Olkkola
Sep 2, 2008·Journal of Clinical Pharmacology·D J Greenblatt, L L von Moltke
Aug 1, 1997·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·C W BertholdS E Corey
Feb 8, 2006·The Journal of Allergy and Clinical Immunology·Mutasem M Rawas-QalajiKeith J Simons
Sep 30, 2005·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·H C RawdenJ B Houston
Dec 18, 2001·Biopharmaceutics & Drug Disposition·A WeberJ D Unadkat
May 5, 2017·Drug Testing and Analysis·Kieran R ManchesterPeter D Maskell
Oct 3, 1998·Clinical Pharmacology and Therapeutics·D J GreenblattR I Shader
Jun 2, 2001·Journal of Clinical Psychopharmacology·C M TweedyS E Coldwell
Jun 1, 1997·Journal of Clinical Psychopharmacology·H W KarlD Mautz
Aug 10, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·D J GreenblattR I Shader
Jun 2, 2009·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·T TachibanaY Sugiyama
Jun 14, 2006·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·E M HowgateA Rostami-Hodjegan

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.